Invitae Sues Natera Over Alleged Infringement of Sequence Assembly Patents
Invitae is seeking damages and other costs, as well as an order enjoining Natera from infringing its '308 and '863 patents, which were granted last month.
Evolution of Dengue Virus Antigens Reflected in Outbreaks in Thailand
An international team sequenced 1,944 dengue virus isolates collected in Bangkok over 20 years as part of an effort to follow DENV antigen evolution.
Agilent Q4 Revenues Rise 12 Percent
Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter.
Stilla Technologies Raises €31.3M in Financing
The firm will use the funds to further expand its global commercial presence and develop a next-generation digital PCR system.
Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris
The firm has entered into a definitive agreement to acquire Abveris, an antibody discovery company, for up to $190 million in stock and cash.